Bayer NV/SA
Kouterveldstraat 7A 301
1831 Diegem
BE
Bayer NV/SA
Foundation date
20/07/1961
Sector
#PharmaSubsector
- #Therapeutics - Cell therapy
- #Therapeutics - Drug delivery
- #Therapeutics - Gene therapy
- #Therapeutics - Molecular diagnostics
- #Therapeutics - Small molecules
- #Therapeutics - Anti-infectives
Therapeutic areas
- #Cardiovascular
- #Diseases of the blood and blood-forming organs - immune disorders
- #Diseases of the eye
- #Infectious and parasitic diseases
- #Neoplasms / cancer / oncology
- #Pregnancy - childbirth and the puerperium
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
9 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
1 day ago
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
-
20/11/24
Antwerp
Postdoc position in the Laboratory for Gut-Immune-Brain Axis Research
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator